Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BD-3000 MICROKERATOME SYSTEM, MODEL K-3000 MICROKERATOME

K-Number: K022637 · 2002-10-16

ApplicantBecton, Dickinson & CO
Decision Date2002-10-16
Product CodeHMY
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

BD-3000 MICROKERATOME SYSTEM, MODEL K-3000 MICROKERATOME is the device name listed in this FDA 510(k) record. The listed applicant is Becton, Dickinson & CO. It received FDA 510(k) clearance on 2002-10-16 under 510(k) number K022637. The device is classified under product code HMY. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BD-3000 MICROKERATOME SYSTEM, MODEL K-3000 MICROKERATOME?

BD-3000 MICROKERATOME SYSTEM, MODEL K-3000 MICROKERATOME is a medical device that received FDA 510(k) clearance on 2002-10-16. The listed applicant is Becton, Dickinson & CO. The 510(k) number is K022637.

When did BD-3000 MICROKERATOME SYSTEM, MODEL K-3000 MICROKERATOME receive FDA 510(k) clearance?

BD-3000 MICROKERATOME SYSTEM, MODEL K-3000 MICROKERATOME received FDA 510(k) clearance on 2002-10-16, under 510(k) number K022637.

Who is the listed applicant for BD-3000 MICROKERATOME SYSTEM, MODEL K-3000 MICROKERATOME?

The FDA 510(k) record lists Becton, Dickinson & CO as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BD-3000 MICROKERATOME SYSTEM, MODEL K-3000 MICROKERATOME?

The FDA product code for BD-3000 MICROKERATOME SYSTEM, MODEL K-3000 MICROKERATOME is HMY.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Becton, Dickinson & CO as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K160164BD Veritor System for Rapid Detection of Flu A + B Labratory KitK160161BD Veritor System for Rapid Detection of Flu A + B CLIA waived kitK133140BD VERITOR SYSTEM FOR THE RAPID DETECTION OF RSVK133138BD Veritor™ System Flu A+B AssayK130268BD PROBETEC TRICHOMONAS VAGINALIS (TV) QX AMPLIFIED DNA ASSAYK131301BD FACS SAMPLE PREP ASSISTANT III

View all 190 devices →

Related Devices (Code: HMY)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K040297ONEUSE- PLUS MICROKERATOMEMoria SAK023092BD K-4000 MICROKERATOME SYSTEMBecton, Dickinson & COK022560M2 SINGLE USE MICROKERTOMEMoria SAK003594CARRIAZO BARRAQUER SINGLE USE MICROKERATOMEMoria, Inc.K002191CARRIAZO BARRAQUER II MICROKERATOMEMoria, Inc.K992687MILLENIUM MICROKERATOME, MODEL IMD-001Industrial & Medical Design, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑